TrakCel, a supplier of cellular orchestration solutions for the cell and gene therapy industry, has launched the latest version of its lead next-generation cellular orchestration platform, OCELLOS 3.0.   OCELLOS 3.0 provides the ability to deal with multiple indications and multiple patient populations for each therapy, according to the company. This allows stakeholders to manage all indications, patient groups or trials associated with a therapy from a single TrakCel platform. Data can also b...